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Objectives: Evidence based medicine has been used for about two decades as 
methodology for obtaining, evaluating and presenting information on health 
related topics. The present study investigated the question of the appearance 
of the ideas of evidence based medicine in documents describing the function-
ing of European health care systems. MethOds: The documents available in the 
European Observatory on Health Systems and Policies database were considered 
to reliable represent the health system of European countries. Structured text 
analysis was carried out according to previously described methodology. All evalu-
ation steps were carried out in parallel by two researchers (K.M. and Sz.L.). Two 
studies carried our previously on related topics were used to relate the results 
obtained in the present study with data of the literature. Results: The cumula-
tive length of the documents was 6449 pages; there was no document without 
mentioning the idea of evidence based medicine. Among the altogether 413 men-
tioning of evidence based medicine, we were able to categorise 208 representa-
tions of the idea into one of the following 4 topics: 1. resources of health care, 2. 
health technology assessment, 3. organisation of health care and 4. environment 
of health care within the society. Evidence based medicine was mentioned 57 
in connection with the resources of health care, whereas 31 mentioning were 
related to health technology assessment. Organisation of health care was men-
tioned together with evidence based medicine at 56 occasions, whereas the idea 
of evidence based medicine was related to the social environment of health care 
in 64 instances. cOnclusiOns: The results of the present data collection indicate 
that the methodology of evidence based medicine has already been widely used 
within the documents describing health systems and policies in Europe. However, 
there were considerably differences in the extent and depth of applying evidence 
based medicine methodology.
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Objectives: Pharmacoeconomics is the application of economics to assess 
pharmaceutical and health care products that helps evaluate economic, clinical 
and humanistic outcomes of health care products and interventions. It gives 
health care decision makers, providers and patients with valuable informa-
tion for optimal use and allocation of limited health care resources. In India, 
the awareness of pharmacoeconomics is relatively low among policy makers, 
academia and industry. As India’s pharmaceutical market changes and evolves, 
the study of pharmacoeconomics and associated research is expected to gain 
momentum. MethOds: Secondary research was conducted using PubMed. 
Several search terms like “pharmacoeconomics”, “cost minimization”, “cost 
benefit”, “cost utility”, and “cost effectiveness” analysis were used. These terms 
were also used in different combinations, e.g., “Cost Minimization Analysis and 
Pharmacoeconomics and India”, “Cost Benefit Analysis and Pharmacoeconomics 
and India”, to extract relevant studies. No search term or time restrictions 
were applied while extracting studies. Results: Overall, a total of 228 stud-
ies were extracted using the search terms. “Pharmacoeconomics and India” 
yielded 192 results out of which only five studies were relevant to pharmaco-
economics in India. Search terms “Cost Minimization Analysis and India and 
Pharmacoeconomics” gave only two results. Fifteen results were obtained for 
the term “Cost Benefit Analysis and Pharmacoeconomics and India” out of 
which four studies were relevant to the objective. “Cost Utility Analysis and 
Pharmacoeconomics and India” resulted in four results out of which two were 
repetitions of results from “cost minimization analysis”. “Cost effectiveness 
analysis and pharmacoeconomics and India” resulted in 15 results; 10 in last 
10 years and only 2 were relevant. cOnclusiOns: As seen from the results, not 
much pharmacoeconomic research has been conducted in India suggesing the 
dearth of literature in this area in India. As the Indian pharmaceutical market 
evolves and policies change, greater amount and rigorous pharmacoeconomics 
research may be needed.
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Sichuan University, Chengdu, China
Objectives: To explore the attitudes and perceptions of patient safety culture for 
health care workers in China by using a modified Hospital Survey on Patient Safety 
Culture (HSPSC) questionnaire. MethOds: The survey measuring 10 dimensions 
of patient safety culture with 36 items was conducted from 32 hospitals in 15 cit-
ies all across China. We computed descriptive statistics and Chi-Square test was 
performed to explore the differences on the perception of patient safety culture 
in groups of different work units, positions and qualification levels. SPSS 17.0 was 
used to perform data extraction and analysis. Results: A total of 1500 question-
naires were distributed of which 1160 were responded validly (response rate 77%). 
Seven hundred and twenty two (66%) of the respondents were nurses, 386 (33%) 
were surgical clinicians and 343 (30%) were internal medicine clinicians. The posi-
tive response rate for the 10 patient safety culture dimensions ranged from 45% 
to 88%, the mean positive response rate was 65%. The lowest positive response 
rate of dimension was “Staffing” (45%), while the highest positive response rate of 
dimension was “Organization Learning-Continuous Improvement” (88%). The positive 
response rate of two dimensions of nurse was lower than that of physicians (“Overall 
Perceptions of Patient Safety” and “Communication Openness” P < 0.05). Furthermore, the 
positive response rate of physicians with high qualification (chief physicians) on 
two dimensions (“Overall Perception of Patient safety” and “Feedback & Communication 
About Errors” P < 0.05) was higher than those having a low qualification level (resi-
dents). cOnclusiOns: The results show that amongst the health care workers 
surveyed in China there was a positive attitude towards the patient safety culture 
within their organizations.
this study was to assess the trends which drive risk sharing agreements with the 
Pharmaceutical Benefits Advisory Committee (PBAC) within a four month period in 
2013. MethOds: All PBAC decisions from August to November 2013 were surveyed 
by looking at the general RSA structures outlined in the PBAC guidelines. The fol-
lowing data were extracted from each appraisal: assessment outcome (positive or 
negative), RSA consensus (yes or no), RSA type (rebate and recovery, price volume, 
data provision, shared deeds), therapeutic area, product price, product incremen-
tal cost-effectiveness ratio, market size, structure of trial, trial outcomes, and the 
availability of alternative therapies. Results: The analysis revealed that 44% of 
PBAC decisions incorporated some form of an RSA, and 91% of products with RSAs 
received a positive PBAC decision. The majority of RSAs were rebate recovery or price 
volume arrangements, where the PBAC was concerned with the product’s use in a 
larger-than-specified population. cOnclusiOns: The results of this study indicate 
the PBAC readily enters into RSAs when doubt exists surrounding the potential cost 
or efficacy of a drug. Accurately identifying areas of product risk and proposing an 
RSA to address it can lead to a favourable decision from the PBAC.
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Objectives: The objective of this study was to compare the Health Technology 
Assessment (HTA) timing and decisions for recently launched products in South 
Korea and Taiwan, and to provide insight into launch strategies in these mar-
kets. MethOds: We analysed all products that were assessed for reimbursement 
by the Health Insurance Review & Assessment Service (HIRA) in Korea and by 
the National Health Insurance Administration (NHIA) and the Centre for Drug 
Evaluation (CDE) in Taiwan from January 2012 to March 2014. Where relevant, the 
details of the assessments have been extracted from the NHIA meeting minutes, 
CDE reports and HIRA reports. Results: Since January 2012, 17 products were 
assessed by the reimbursement authorities in both Korea and Taiwan. 12 products 
received the same reimbursement decisions from both countries, while five prod-
ucts had divergent results. Of 12 products that received the same decisions, seven 
products were first assessed and reimbursed by Korea and then also reimbursed 
in Taiwan later, while only three products were first assessed and reimbursed by 
Taiwan and later followed by Korea. The other two products were assessed at the 
same time in both countries. Of five products that received different reimburse-
ment decisions, two products were first assessed by Korea and Taiwan respectively, 
while the other product was assessed at the same time in both countries. Though 
the sample size is limited, these data suggest a possible positive influence of 
Korean HTA decisions on those in Taiwan. The average time difference between 
the Korea and Taiwan HTA assessments was 7.7 months, while Taiwan HTA assess-
ments, on average, lagged behind Korea by 2.6 months. cOnclusiOns: In general, 
Taiwan HTA assessments lag behind Korea by 2-3 months. This may result from a 
proactive launching strategy from manufactures, as HTA decisions made in Korea 
may have a positive influence on those in Taiwan.
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Fudan University, China, Shanghai, China
Objectives: More and more papers about pharmacoeconomics and outcome 
research were published in China. The aim of this study was to evaluate the quality 
of Chinese pharmacoeconomics study and outcome research through analyze 
papers published in the peer-reviewed literature in Chinese over the last five 
years. MethOds: We conducted full-text paper searches in public databases from 
2009 to 2013 in China. A search strategy and inclusion criteria were set up to iden-
tify the articles to be included. The search identified 820 studies, of which 411 were 
included. Then papers were evaluated through a framework which was based on 
Pharmacoeconomics guideline. Results: Our results showed that a large number 
of published studies were of suboptimal quality. Most of pharmaceonomics and 
outcome research were conduct by doctors (33.6%) and pharmacists (54%) in China. 
Prospective studies (65.9%) were the most common study design, while most data 
were derived from the clinical trials; Only 8% of them included articles clearly 
stated the study perspective; More than half studies (56.2%) only computed drug 
expenditure in cost estimation; 2.2% of articles conducted discounting; 63.5% of 
studies performed the incremental analysis, however, most studies presented 
the cost-effectiveness ratios as incremental cost-effectiveness ratio; Sensitive 
analysis were reported by 71.3% of the included studies, nonetheless, the choice 
of variables for sensitivity analysis wasn’t justified; A few studies (7.3%) presented 
the transferability of the results. cOnclusiOns: The above data signify that the 
quality of pharmacoeconomic evaluations needs improvement. There were just 
few studies which had well-designed schemes, high-qualified data and suitable 
methodology, partly owing to the doctors and pharmacists’ lack of pharmaceo-
nomics expertise and knowledge. It implied China should improve the training 
of pharmaceonomics and outcome research training in doctors and pharmacists. 
Moreover, a further study of the new technology on pharmacoeconomy should 
not be neglected.
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Objectives: Improving and promoting rational drug use is a great interest. We 
aimed to assess the effectiveness and cost-effectiveness of prescribing audit and 
feedback intervention in improving physician prescribing. MethOds: A four-arm 
randomized trial with economic evaluation conducted in Tehran. Three interven-
tions (routine feedback, revised feedback, and printed educational material) and 
a no intervention control arm compared. Physicians working in outpatient prac-
tices were randomly allocated to one of the four arms using stratified randomized 
sampling. The interventions were developed based on a review of literature, physi-
cian interviews, current experiences in Iran and with theoretical insights from the 
Theory of Planned Behavior. Effects of the interventions on improving antibiotics 
and corticosteroids prescribing assessed in regression analyses. Cost data assessed 
from a health care provider’s perspective and incremental cost-effectiveness ratios 
calculated. Results: Comparing the new-design feedback arm and the no inter-
vention arm, we observed significant reductions in the proportion of prescriptions 
including Dexamethasone injectable (1.64 difference in percentage change; p value: 
0.006) and Cefixime (0.99 difference in percentage change; p value: 0.01). We also 
observed significant reductions in the printed educational material arm’s propor-
tion of prescriptions including Cefixime (0.93 difference in percentage change; 
p value: 0.04) as compared with the no intervention arm. ICER values correspond-
ing to Dexamethasone injectable and Cefixime were 0.41 and 1.03 US$ per unit 
reduction in the number of prescriptions respectively. cOnclusiOns: According 
to the results of this study, we recommend that a careful attention to the format, 
design and the way the messages are conveyed in feedback forms is an important 
indicator of audit and feedback’s potential success in improving prescribing behav-
ior. Considering the incremental cost-effectiveness ratio, the cost-effectiveness of 
new-design feedback intervention arm has been proved.
PHP79
training HigH-level local researcHers to imProve tHe Quality oF 
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Zhou X., Sun X., Li Y.
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Objectives: Analyzing all randomized controlled trials (RCTs) published in The 
Lancet in 2013 to to discuss the influence factors on the publication of high-quality 
clinical studies. MethOds: We included all RCTs published in The Lancet in 2013. 
The information about the research topic and the number of included participants, 
the first author’s region and type of research institution, and the participants’ region 
were collected, and analyzed their proportions. Results: 110 eligible RCTs with 
734,085 participants were included. The top three topics of the RCTs were infec-
tious diseases 22 (20.0%), cardiology and vascular medicine 17 (15.5%), oncology 12 
(10.9%), but the top three number of participants were 210,350 (28.7%) in obstetrics 
and gynaecology, 198,471 (27.0%) in oncology, and 154,637 (21.1%) in infectious dis-
eases. The proportion of RCTs which enrolled participants from developed coun-
tries is 86.4%, only 13.6% ones enrolled participants in developing countries. The 
first authors from the developed and developing countries were 87.3% and 12.7% 
respectively, which was the same as participants. 52.7% RCTs were done by univer-
sities, only 25.2% and 13.6% were conducted by hospitals and research institutions 
respectively. cOnclusiOns: Developing countries have a most heavy burden of 
diseases but serious shortage of high-level clinical researchers. Using results from 
developed countries to guide the prevention and treatment of even the same dis-
eases in the developing countries may not proper due to various local conditions. 
We appeal to promote the cooperation between the universities and hospitals in the 
developed and developing countries. The localization of the training material should 
be encouraged to train more high-level local clinical researchers and produce more 
high-quality clinical evidences for the developing countries through joint-program.
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Objectives: The objective of this study was to compare the Health Technology 
Assessment (HTA) reimbursement recommendations from 6 HTA agencies using 
a HTA process taxonomy. MethOds: Using a previously published categorisation 
process, six HTA agencies were assigned to one of three distinct taxonomic groups 
based on processes for conducting therapeutic value (TV), economic value (EV) or 
appraisal activities: A – TV with independent appraisal; C – TV, EV and appraisal 
combined; I – appraisal independent of TV and EV. Agencies were classified as: 
A- the Health Care Insurance Board (CVZ) in The Netherlands and the French 
National Authority for Health (HAS); C- the National Authority of Medicines and 
Health Products (INFARMED) in Portugal and the Scottish Medicines Consortium 
(SMC); I- the Agency for Health Technology Assessment (AHTAPol) in Poland and the 
National Institute of Care and Health Excellence (NICE) in England. Reimbursement 
recommendations were collected for medicines granted centralised European mar-
keting approval from January 2007 to December 2009 and which were reviewed by 
at least two target HTA agencies. Jurisdictional economic and demographic data 
were collected to further refine the taxonomy. Results: 71 products with 271 
HTA recommendations were categorised by taxonomy to reveal congruence of 86% 
(n= 49) for A, 63% (n= 19) for I, and 44% (n= 25) for C. Congruence between dissimilar 
taxonomies ranged from 47% to 96% and suggest the reimbursement recommen-
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researcH on HealtH services need and utilization oF tHe rural 
elderly leFt at Home in sHaanxi Province, cHina
Liu J., Wu J., Mao Y.
Xi’an Jiaotong University, Xi’an City, China
Objectives: Based on the survey data of Shaanxi Province in 2012, this paper ana-
lyzed the situation of health services need and utilization of the rural elderly left 
at home (relaH), and discussed their influencing factors. MethOds: 1) Four-steps 
modeling method. Based on this method, we built four regression models which 
were the logistic regression models of two-week out-patient rate and hospitaliza-
tion rate last year, and the linear regression models of the logarithmic out-patient 
expenses and the logarithmic in-patient expenses. 2) Logistic regression analysis. 
It was used to analyze the influencing factors of health services need and utiliza-
tion of the RELAH. 3) Chi-square test. We used it to make comparison analysis on 
health services need and utilization between the RELAH and the normal rural 
elderly. Results: 1) The health status of the RELAH are poorer, many of their 
health services demands haven’t been got released compared with the normal 
rural elderly, and the features of health services of the rural oldest old left at home 
are high need but low utilization. 2) The influencing factors of health services 
need of the RELAH mainly include education, occupation, income level, age and 
whether living together with their grandchildren. 3) The influencing factors of 
health services utilization of the RELAH mainly include marriage, income level, 
age, accessibility to health services, living together with their grandchildren, being 
required hospitalization last year, suffering from chronic diseases and the types 
of medical institutions for treatments. cOnclusiOns: Combined with research 
results, we give some suggestions. Firstly, perfect the compensation mechanism 
of medical institutions to reduce patients’ medical expenses. Secondly, make the 
land expropriation reasonably, and avoid farmers suffering from the jobless situ-
ation. Thirdly, develop the family doctor system actively. Fourthly, develop the 
county economy, reduce the families’ numbers of the RELAH and ensure them 
have families’ accompanying when ill.
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Hearing tHe Patient’s voice in HealtH care: a survey analysis  
oF Patients’ PercePtions oF diFFiculties in sHared clinical  
decision-maKing
Jia P., Zhang L., Mao X., Zhang M.
Sichuan University, Chengdu, China
Objectives: To explore the factors which affect shared decision-making and 
develop strategies to get patients actively involved in clinical decision-mak-
ing. MethOds: The survey was conducted in one of the Third-grade hospitals in 
southwest part of China for a total of 565 patients involved. SPSS 17.0 was used to 
perform data extraction and analysis. Results: The survey yielded to 600 question-
naires with a 94% response rate. There were 68% patients who had some knowledge 
of the disease. Most of the patients (92.94%) have a positive attitude to participate 
in clinical decision making and 95% patients hope to know the medical information 
of treatment. Account for 60.24% patients would like to obtain information from 
doctors. While, only 46.21% patients can achieve the goals. Meanwhile, There were 
79.2 % patients who are satisfied with the current treatment plan. The patients’ big-
gest concerns were: treatment effect, cost and doctors’ skills. The biggest difﬁculties 
that patients worried about were: long-time waiting in out-patient departments 
(50.47%) and limited time to communicate with doctors (37.08%). cOnclusiOns: 
As more and more patients would like to involve in shared decision-making, doctors 
need to provide patients with more choices and help them make a right decision 
in their treatment. A successful bidirectional way between and patients will obtain 
patients’ trust and cooperation.
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Objectives: Strategic purchasing aims at maximizing health system performance 
and takes the health preference of people as basis to decide which interventions 
should be purchased, how and from whom they can buy them. At present China, 
the purchasing arrangements are not perfect and several issues should be resolved 
urgently. Moreover, the limited research findings have not proposed effective solu-
tions. Therefore this research project is considerably necessary and significant. 
The objectives of this study is to describe the purchasing arrangements in current 
China, analyze the factors which block the system performance, and propose what 
roles are purchasers expected to play in progress towards universal health cover-
age (UHC) from the perspective of strategic purchasing. MethOds: This study 
applies the model of multiple principal-agent relationship to the examination 
of relationships among the performers within the new rural cooperative medical 
scheme (NCMS) in China. We obtain information from case study and qualitative 
study by interviewing key people. Three provinces including Qinghai, Henan and 
Shandong have been chosen as our study sites with purposive sampling. In addi-
tion, provincial and county level leaders will also be interviewed. We critically 
assess the actual purchasing performance by comparing it with ideal strategic 
purchasing mechanism, recognize hindering factors which influences the system’s 
performance, and finally propose suggestions for policy making. Results: The 
results indicate that the accessibility, efficiency, and quality of primary health 
services in present China are low. Practice of strategic purchasing is limited and 
the purchasers could not fully represent community’s preference. Meanwhile, 
purchasers are lack of control on health care providers and stewardship of gov-
ernment is not adequate. cOnclusiOns: Enhancement of strategic purchasing 
mechanism needs to better coordinate principle- agent relationships between 
different actors, create appropriate incentives by adopting mixed provider pay-
ment methods and contracting with providers. Key words: Strategic purchasing; 
multiple principal-agent model; financing; people preference.
